PASCALL Systems, Incorporated
Boston, MA · Medtech · Private
Intraoperative nociception monitoring system using event-related potentials (ERPs) to assess surgical pain and analgesia efficacy during general and regional anesthesia
pascallsystems.com →- Grants
- $23M
- 22 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients | $449,671 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements | $349,937 | |
| Federal grant | Department of Health and Human Services · Phase II · Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients | $1,227,656 | |
| Federal grant | Department of Health and Human Services · Phase II · Personalized anesthetic brain monitoring:Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients | $2,442,591 | |
| Federal grant | Department of Health and Human Services · Phase II · Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients | $1,214,935 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements | $1,976,676 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements | $981,839 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care | $474,416 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients | $299,893 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements | $987,966 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia to minimize postoperative opioid requirements | $221,325 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias | $499,968 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care | $1,208,662 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor | $399,269 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias | $1,245,833 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementias | $1,499,986 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care | $1,255,373 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients | $998,162 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor | $1,089,346 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Developing an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementias | $1,499,986 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias | $1,236,964 | |
| Federal grant | Department of Health and Human Services · Phase II · Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients | $999,317 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1697 | TEARDX, LLC | — | — |
| 1698 | ONTOGEN MEDTECH | — | — |
| 1699 | Amnio Technology, LLC | — | $50K |
| 1700 | PASCALL Systems, Incorporated | — | — |
| 1701 | Peltier Technology Inc. | — | $5.6M |
| 1702 | YORK SOUND INC | — | — |
| 1703 | ANVIL DIAGNOSTICS INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.